Skip to main content

Table 2 End points after 24 and 48 weeks of treatment

From: Effectiveness of enfuvirtide in a cohort of highly antiretroviral-experienced HIV-1-infected patients in Mexico

Outcomes

Median (IQR)

p value

 

Baseline

Week 24

Week 48

24/48 weeks

CD4+ cells count

225 (110–478)

301 (216–549)

443 (260–585)

<0.0001*

HIV-1 RNA viral load

17,677 (3,702–92,555)

50 (<50–137)

50 (<50–185)

<0.0001*

Cholesterol (mg/dL)

174 (154–196)

193 (156–230)

195 (169–217)

0.158/0.170

Triglycerides (mg/dL)

204 (159–290)

258 (220–374)

267 (166–302)

0.016/0.372

Creatinine (mg/dL)

0.9 (0.77–1.0)

1.0 (0.9–1.1)

1.0 (0.8–1.1)

0.157/0.091

  1. *At both 24 and 48 weeks.